Health

Frontline is a venture firm supporting globally ambitious B2B companies across the Atlantic. Frontline Seed boosts early-stage ideas in Europe, while Frontline Growth aids late-stage U.S.-Europe expansion.

Frist Cressey focuses on accelerating high-potential healthcare enterprises through value-added partnerships, investing in tech and service businesses that enhance care quality, system integration, and patient outcomes.

Invests in early-stage companies leveraging technology and data for industrial, enterprise, and healthcare sectors.

Supports ambitious founders eager to disrupt the status quo.

GAN Ventures, the investment arm of the Global Accelerator Network, invests in founders wherever they are. They believe in fostering community prosperity globally by helping founders create sustainable jobs, revenue, and local institutions.

Giant Ventures supports tech founders working towards a more sustainable, equitable, and resilient future.

Gold House Ventures is the leading fund investing in high-growth Asian and Pacific Islander entrepreneurs transforming industries. They support API ventures with capital, tools, and connections for accelerated growth, through their fund, accelerator, and exclusive network.

Funds companies led by women in key leadership roles.

An early-stage VC firm founded by entrepreneurs and operators behind $300 billion in company value. GreatPoint partners with founders tackling major issues in enterprise, healthcare, biotech, and food, making fewer than 10 investments annually to maintain deep engagement.

Comprises over 250 diverse teams across 30 states and 19 countries, all committed to reshaping the Internet economy.

Hannah Gray, founded by Kate Beardsley and Jessica Peltz-Zatulove, is a first check fund investing in customer-focused founders redefining everyday experiences.

Headline is a global VC firm investing in rising B2B and B2C founders, with teams in 7 cities worldwide. Since 1998, Headline has worked closely with globally ambitious founders, providing them with connections, resources, and insights to achieve global success.

HTH is an investment and advisory firm investing in health-focused innovators since 2016. They work closely with pharma companies to fund life science ventures, provide corporate innovation capabilities, and open stakeholder networks. Their science-first approach involves deep due diligence, including data, models, and clinical expert interviews, typically completed within 1-2 months.

Healthy Ventures invests in enterprise and developer-facing healthcare solutions. They provide deep healthcare and market knowledge, a dedicated go-to-market strategy, and a robust network to support founders throughout their journey.

Committed to closing the VC gender gap by investing in and supporting women.

Founded by Dr. Ling Wong, this firm funds companies using science and technology to create a better future.

A New York-based global, multistage technology-focused VC helping ambitious founders build enduring businesses, from idea to IPO, and structuring transformational partnerships with enterprises through its LP network.

Homebrew is a seed-stage fund providing operational expertise for mission-driven entrepreneurs with bold ideas, big impact, and a willingness to take significant risks.

A venture firm with $1.5B in committed capital, building a community of over 5,000 driven and ambitious builders.

Specializes in early-stage investments in fintech startups.

Funds early-stage companies blending engineering with physical and life sciences to create technologies that solve pressing global challenges.

Prefers scrappy founders with a bootstrap mentality—frugal and resourceful. Focus areas: B2B, fintech, web3, and digital health. Not focused on: consumer, marketplaces, and e-commerce. Comfortable with pre-revenue, earlier stages preferred.

An early-stage venture fund focused on supporting software engineers and designers by providing initial seed capital, giving these creators the early support needed to launch their ventures.

Vituity’s corporate venture division invests in healthcare-focused seed-stage startups, aiming for strategic co-investments that bring innovation to medical care services.

Innospark is committed exclusively to artificial intelligence, investing with a builder’s mindset. They are deeply inquisitive, thorough, and invest their personal capital, aiming to push forward AI development.

IVP helps companies grow from emerging startups to lasting market leaders. They focus on strategic support during pivotal moments that shape a business, acting as partners, advisors, and celebrators of success along the journey.

Invests in fast-growing technology firms operating in sizable markets with a strong, defensible competitive position.

Focused on expanding VC opportunities for determined female founders who lack traditional networks or elite education.

Concentrates on innovations that push the boundaries of human performance, aiming for technological advances that amplify human capabilities.

Committed to improving the quality of life for the 99%, K50 invests in early-stage companies that challenge the status quo and aim to make daily life better for everyone, with a target ownership of 5-10%.